Related Articles
CD155 expression and its clinical significance in non‑small cell lung cancer
Programmed death‑ligand 1 positivity can predict improved survival and a lower risk of brain metastasis in patients with resectable small cell lung cancer
CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis
Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma
Expression of PD‑L1 and CD4+ tumor‑infiltrating lymphocytes predict survival in head and neck squamous cell carcinoma